| Patents for C07J 17 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta[a]hydrophenanthrene skeleton (2,111) |
|---|
| 10/20/2010 | CN101863946A Method for extracting high-content mogroside V from dried momordica grosvenori swingle |
| 10/20/2010 | CN101863945A American ginseng saponin F6 as well as extraction method and medical application thereof |
| 10/07/2010 | US20100256078 Neoglycorandomization and digitoxin analogs |
| 10/06/2010 | CN101851265A Method for extracting various active components from dried fructus momordicae |
| 09/30/2010 | WO2010048710A8 Neurotoxic sterol glycosides |
| 09/30/2010 | US20100248218 Conjugates, and use thereof in detection methods |
| 09/16/2010 | WO2010102952A1 Enzymatic removal of steryl glycosides in fatty acid alkyl esters |
| 09/16/2010 | US20100234454 Treatment of cnidaria intoxication |
| 09/15/2010 | CN101830965A Method for catalyzing and hydrolyzing natural nucleoside compound by metal ion |
| 09/15/2010 | CN101829228A Method for extracting digitonin |
| 09/08/2010 | CN101824065A Fatty-acid monoester compound of ginsenoside secondary glycoside Rh1 and preparation method thereof |
| 09/02/2010 | US20100221213 Y-shape branched hydrophilic polymer derivatives, their preparation methods, conjugates of the derivatives and drug molecules, and pharmaceutical compositions comprising the conjugates |
| 09/01/2010 | EP2222690A2 Natural brassinosteroids for use for treating hyperproliferation, treating proliferative diseases and reducing adverse effects of steroid dysfunction in mammals, pharmaceutical composition and its use |
| 08/26/2010 | WO2010095741A1 Novel steroid derivative and process for production thereof, and pharmaceutical preparation comprising the novel steroid derivative |
| 08/17/2010 | CA2584968C Drug and food or drink for improving pancreatic functions |
| 08/12/2010 | US20100204460 Natural brassinosteroids for use for treating hyperproliferation, treating proliferative diseases and reducing adverse effects of steroid dysfunction in mammals, pharmaceutical composition and its use |
| 08/12/2010 | CA2751263A1 Novel saponin compounds, methods of preparation thereof, use thereof and pharmaceutical compositions |
| 08/05/2010 | DE102009006923A1 Removing sterol glycoside containing precipitates in production of fatty acid alkyl esters comprises mixing fats or oils, alkyl and catalyst, and separating mixture into light phase, ester rich phase and heavy, glycerin rich phase |
| 08/05/2010 | DE102009006922A1 Making fatty acid alkyl ester by transesterifying fats or oils with alkyl alcohol and a catalyst, comprises mixing fats or oils, alkyl alcohol and catalyst and separating fatty acid alkyl esters from a light and ester-rich phase and drying |
| 08/05/2010 | DE102009006921A1 Producing fatty acid alkyl esters comprises transesterification of fats or oils with alkyl alcohols, where the fats or oils, the alkyl alcohols and a catalyst are separated into a light, ester-rich phase and a heavy, glycerin-rich phase |
| 08/05/2010 | DE102009006920A1 Producing fatty acid alkyl ester comprises e.g. mixing fats or oils, alkyl alcohols and catalyst, separating mixture into low, ester-rich phase and heavy glycerin-rich phase, and separating fatty acid alkyl ester from low, ester-rich phase |
| 08/05/2010 | DE102009006919A1 Producing fatty acid alkyl ester comprises e.g. mixing fats or oils, alkyl alcohols and catalyst, separating mixture into low, ester-rich phase and heavy glycerin-rich phase, and separating fatty acid alkyl ester from low, ester-rich phase |
| 07/28/2010 | CN101787068A Steroid saponin extract of Smilax riparia A.DC. and preparation method and application thereof |
| 07/21/2010 | CN101781353A 20(S)-ginsenoside Rh2 derivatives for regulating and controlling ER Alpha/ER Beta-TNF Alpha channel as well as preparation and anti-tumor application thereof |
| 07/21/2010 | CN101781352A 20-O-glycosyl and protopanoxadiol compound and preparation method thereof |
| 07/21/2010 | CN101781351A Method for extracting ginsenoside Rb1 from American ginseng and powder-injection thereof |
| 07/01/2010 | US20100168406 USE OF GINSENOSIDE Rb2 MONOMER IN THE MANUFACTURE OF MEDICAMENTS FOR THROMBOLYSIS |
| 06/30/2010 | CN101759752A Ginsenoside Rg 1 containing ginsenoside Rg 2 impurity |
| 06/30/2010 | CN101759751A Ginsenoside Rg 1 containing ginsenoside Re impurity |
| 06/30/2010 | CN101759750A Ginsenoside Rg 1 containing ginsenoside Rh 1 and ginsenoside F1 impurities |
| 06/30/2010 | CN101759749A Ginsenoside Rg 1 containing ginsenoside Rf and/or pseudo-ginsenoside F11 impurity |
| 06/16/2010 | CN101735885A Method for extracting shelled cedar seed oil and daucosterol from shelled cedar seed |
| 06/10/2010 | US20100144688 23-Substituted Derivatives of Lupane-type Pentacyclic Triterpenoids |
| 06/09/2010 | CN101724003A Ginsenoside Rg1 containing impure notoginsenoside R1 |
| 05/27/2010 | WO2010058794A1 Antioxidant |
| 05/27/2010 | CA2742946A1 Antioxidant |
| 05/26/2010 | EP2188300A2 Novel sweetener iso-mogroside v |
| 05/12/2010 | CN101205247B Method for preparing panaxoside monomer Re,Rh1,Rh2,Rg2,Rg3 by using ginseng stem and leaves |
| 05/06/2010 | WO2010048710A1 Neurotoxic sterol glycosides |
| 04/30/2010 | CA2665773A1 Neurotoxic sterol glycosides |
| 04/22/2010 | WO2010004423A3 Method |
| 04/15/2010 | WO2010041681A1 Novel sominone derivative |
| 03/18/2010 | WO2010029915A1 Method for producing a composition with a high content of sapogenin |
| 03/17/2010 | CN101671385A Triterpene glycosides antifungal compounds of sea cucumber HolotoxinD-I and preparation method thereof |
| 03/17/2010 | CN101671384A Method for preparing ginsenoside Rh1 |
| 03/11/2010 | WO2010027992A1 Method of preventing preeclampsia |
| 03/10/2010 | EP1023315B1 Methods and compositions for destruction of selected proteins |
| 03/10/2010 | CN101665527A Ginsenoside, preparation method thereof and use thereof |
| 03/04/2010 | US20100056767 Selective separation or extraction of steroidal glycosides by supercritical fluid extraction using carbon dioxide |
| 03/04/2010 | US20100056488 Corticosteroid conjugates and uses thereof |
| 02/24/2010 | EP2156840A2 Use of mometasone furoate for treating airway passage and lung diseases |
| 02/24/2010 | CN101654470A Intermediate used as anti-inflammatory androstane derivative compositions and uses thereof |
| 02/16/2010 | CA2287387C Methods and compositions for destruction of selected proteins |
| 01/27/2010 | CN100584856C Hedera helix saponin, preparation method and antineoplastic use thereof |
| 01/20/2010 | CN100582119C Process for separating diol ginsenoside and triol ginsenoside |
| 01/14/2010 | CA2732246A1 Method |
| 01/12/2010 | CA2110111C Production of saccharide carboxylic acids |
| 12/23/2009 | EP2135611A1 Pregn-5-en-20-yne-3,7,17-triol derivatives for use in therapy |
| 12/22/2009 | CA2454799C Novel dammarane sapogenins, their use as anti-cancer agents, and a process for producing same |
| 12/09/2009 | CN101597314A Preparation method of ginsenoside Rg1 |
| 12/08/2009 | US7629335 comprising a drug compound 6 alpha ,9 alpha -Difluoro-17 alpha -[(2-furanylcarbony)oxy]-11 beta -hydroxy-16 alpha -methyl-3-oxo-androsta-1,4-diene-17 beta -carbothioic acid S-fluoromethyl ester; dry powder inhaler; with predictable pharmacokinetic and pharmacodynamic behaviour |
| 11/26/2009 | WO2009106360A3 Method for purifying biodiesel or biodiesel precursors |
| 11/24/2009 | CA2338342C Conjugates of dna interacting groups with steroid hormones for use as nucleic acid transfection agents |
| 11/12/2009 | WO2009135449A1 LIGANDS OF ESTROGEN RECEPTORS α AND β, METHOD OF THEIR PREPARATION AND PHARMACEUTICALS COMPRISING THEM |
| 11/11/2009 | CN101575357A Method for preparing notoginsenoside R1 and ginsenoside Rg1, Re, Rb1 and Rd |
| 10/28/2009 | CN101565443A New fir triterpene lactone compound, preparation method and application thereof |
| 10/15/2009 | US20090259038 Process for producing (5alpha7alpha)-3-spiro-2'-(1',3'-dioxolan)-24-oxocholest-22-en-7-yl benzoate |
| 10/13/2009 | US7601706 Bile-acid conjugates providing for sustained systemic concentration of drugs |
| 09/29/2009 | CA2434009C Conjugates of immune cell specific macrolide compounds with anti-inflammatory compounds for improved cellular targeting of anti-inflammatory therapy |
| 09/23/2009 | CN101538308A Method for extracting and preparing high-purity ginsenoside Re from herminium by high speed counter current chromatography |
| 09/22/2009 | US7592329 containing an anti-inflammatory and anti-allergic compound of the androstane series |
| 09/15/2009 | CA2533784C Glycoside having 4-methylergost-7-en-3-ol skeleton and hyperglycemia improving agent |
| 09/09/2009 | EP2098585A1 Method for purifying biodiesel or biodiesel precursors |
| 09/03/2009 | WO2009106360A2 Method for purifying biodiesel or biodiesel precursors |
| 09/02/2009 | CN101519419A Semi-synthetic method of pseudo-ginsenoside F11 |
| 08/25/2009 | US7579334 Compounds with anti-inflammatory activity |
| 08/18/2009 | US7576055 Comprised of three lipid elements: phosphatidyl choline, fatty-acyl-cholesterol esters, and at least one apolipoprotein; brain disorders; kits; efficiently target and deliver substances |
| 08/12/2009 | CN101505772A Process for preparing a composition comprising steroidal glycosides |
| 08/05/2009 | EP2083798A1 Pharmaceutical compositions and nasal spray incorporating anhydrous mometasone furoate |
| 08/05/2009 | EP2083621A2 Modulators of amyloid-beta production |
| 08/05/2009 | CN101497641A Method for synthesizing delta 24(28) cholesterol compounds |
| 08/04/2009 | CA2651171A1 Natural sweetner and methods of manufacturing thereof |
| 07/29/2009 | CN100519575C Glycoside having 4-methylergost-7-en-3-ol skeleton and drug for ameliorating hyperglycemia |
| 07/18/2009 | CA2650135A1 Process for obtaining dried plant material |
| 07/16/2009 | WO2009024103A3 Natural brassinosteroids for use for treating hyperproliferation, treating proliferative diseases and reducing adverse effects of steroid dysfunction in mammals, pharmaceutical composition and its use |
| 07/15/2009 | CN100513416C Compounds useful in the manufacture of an anti-inflammatory androstane derivative |
| 06/24/2009 | CN101463061A Ginseng saponin Rg1 and Rb1 in pseudo-ginseng and preparation of total saponin thereof |
| 06/24/2009 | CN101463060A Marsdenia tenacissima extract |
| 06/23/2009 | CA2393135C Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 06/18/2009 | US20090156567 Novel anti-inflammatory androstane derivative |
| 06/10/2009 | EP2067784A2 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivates as anti-flammatory agents |
| 06/09/2009 | CA2388939C Therapeutic treatments for blood cell deficiencies |
| 06/03/2009 | CN101445544A Method for preparing ginsenoside Rb<1> |
| 06/02/2009 | US7541350 Formulation containing anti-inflammatory androstane derivative |
| 05/27/2009 | CN101440118A Saponin compound extracted from Momordica grosvenori root, preparation and use thereof |
| 05/27/2009 | CN101440114A Methods for sulphation modification of 20(S)- ginsenoside Rh2, and separation and identification of sodium sulfovinate produced thereby |
| 05/27/2009 | CN101440112A Steroid compound and use thereof |
| 05/20/2009 | EP1208113B1 17beta-acyl-alpha-propynyl-11beta-(cyclic amino)aryl steroids and their derivatives having antagonist hormonal properties |
| 05/19/2009 | US7534770 extract of a plant of the family Liliaceae; Aloe vera; can be safely ingested without causing acute hypoglycemia and has a long-term blood glucose level control action to decrease the hemoglobin Alc level |
| 05/14/2009 | WO2009023975A3 Novel sweetener iso-mogroside v |